Dynavax Technologies Corp financial data

Symbol
DVAX on Nasdaq
Industry
Pharmaceutical Preparations
Location
2100 Powell Street, Suite 720, Emeryville, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.54 K % +252%
Quick Ratio 100 % +183%
Debt-to-equity 60.7 % -34.3%
Return On Equity 1.52 % -96.7%
Return On Assets 0.95 % -96%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 131 M shares +1.87%
Common Stock, Shares, Outstanding 131 M shares +1.86%
Entity Public Float 900 M USD -18.2%
Common Stock, Value, Issued 131 K USD +2.34%
Weighted Average Number of Shares Outstanding, Basic 130 M shares +1.78%
Weighted Average Number of Shares Outstanding, Diluted 130 M shares +1.78%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 236 M USD -64%
Research and Development Expense 54.8 M USD +11.6%
Costs and Expenses 261 M USD -39.8%
Operating Income (Loss) -24.5 M USD -111%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 7.85 M USD -96.7%
Income Tax Expense (Benefit) -1.37 M USD -178%
Net Income (Loss) Attributable to Parent 9.22 M USD -96.1%
Earnings Per Share, Basic 0.07 USD/shares -96.3%
Earnings Per Share, Diluted 0.07 USD/shares -95.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 132 M USD -24.3%
Inventory, Net 61.8 M USD +7.13%
Assets, Current 851 M USD +2.55%
Property, Plant and Equipment, Net 36.4 M USD -4.58%
Operating Lease, Right-of-Use Asset 23.4 M USD -8.03%
Goodwill 2.02 M USD -0.79%
Other Assets, Noncurrent 73.5 M USD -0.66%
Assets 987 M USD +1.72%
Accounts Payable, Current 2.43 M USD -66.7%
Accrued Liabilities, Current 45.8 M USD +64.7%
Liabilities, Current 56 M USD -38.8%
Operating Lease, Liability, Noncurrent 28.6 M USD -11.1%
Other Liabilities, Noncurrent 203 K USD -42.3%
Liabilities 368 M USD -9.38%
Accumulated Other Comprehensive Income (Loss), Net of Tax -4.37 M USD -4.12%
Retained Earnings (Accumulated Deficit) -939 M USD +0.97%
Stockholders' Equity Attributable to Parent 618 M USD +9.71%
Liabilities and Equity 987 M USD +1.72%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -16.7 M USD -160%
Net Cash Provided by (Used in) Financing Activities -4.2 M USD -36%
Net Cash Provided by (Used in) Investing Activities 2.83 M USD
Common Stock, Shares Authorized 278 M shares 0%
Common Stock, Shares, Issued 130 M shares +1.51%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -18.3 M USD +34%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 132 M USD -24.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5.64 M USD 0%
Deferred Tax Assets, Valuation Allowance 180 M USD +0.82%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.24 pure +846%
Deferred Tax Assets, Gross 189 M USD +0.38%
Operating Lease, Liability 33.1 M USD -7.91%
Payments to Acquire Property, Plant, and Equipment 749 K USD -41.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9.05 M USD -96.2%
Lessee, Operating Lease, Liability, to be Paid 46 M USD -11.9%
Property, Plant and Equipment, Gross 69.1 M USD +6.16%
Operating Lease, Liability, Current 4.56 M USD +19%
Lessee, Operating Lease, Liability, to be Paid, Year Two 6.11 M USD -6.98%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.97 M USD -3.12%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 12.9 M USD -20.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 6.04 M USD +2.29%
Deferred Tax Assets, Operating Loss Carryforwards 96.3 M USD -14.9%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) 0 USD
Current Income Tax Expense (Benefit) 2.02 M USD +76.9%
Preferred Stock, Shares Authorized 5 M shares 0%
Unrecognized Tax Benefits 12.1 M USD +6.72%
Lessee, Operating Lease, Liability, to be Paid, Year Four 6.2 M USD +2.62%
Operating Lease, Payments 1.9 M USD +11.8%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 1.53 M USD +70.9%
Current Federal Tax Expense (Benefit) -178 K USD -7.88%
Deferred Tax Assets, Net of Valuation Allowance 9.04 M USD -7.71%
Share-based Payment Arrangement, Expense 0 USD -100%
Deferred State and Local Income Tax Expense (Benefit) 0 USD
Interest Expense 6.77 M USD +0.42%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%